DK0969833T3 - Forlængelse af ekspressionen af transgene proteiner ved immunmodulerende behandling med 15-deoxyspergualin - Google Patents
Forlængelse af ekspressionen af transgene proteiner ved immunmodulerende behandling med 15-deoxyspergualinInfo
- Publication number
- DK0969833T3 DK0969833T3 DK98913712T DK98913712T DK0969833T3 DK 0969833 T3 DK0969833 T3 DK 0969833T3 DK 98913712 T DK98913712 T DK 98913712T DK 98913712 T DK98913712 T DK 98913712T DK 0969833 T3 DK0969833 T3 DK 0969833T3
- Authority
- DK
- Denmark
- Prior art keywords
- expression
- deoxyspergualin
- elongation
- transgenic
- immunomodulatory therapy
- Prior art date
Links
- 230000009261 transgenic effect Effects 0.000 title abstract 3
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- IDINUJSAMVOPCM-UHFFFAOYSA-N 15-Deoxyspergualin Natural products NCCCNCCCCNC(=O)C(O)NC(=O)CCCCCCN=C(N)N IDINUJSAMVOPCM-UHFFFAOYSA-N 0.000 title 1
- BLUYEPLOXLPVCJ-INIZCTEOSA-N n-[(1s)-2-[4-(3-aminopropylamino)butylamino]-1-hydroxyethyl]-7-(diaminomethylideneamino)heptanamide Chemical compound NCCCNCCCCNC[C@H](O)NC(=O)CCCCCCNC(N)=N BLUYEPLOXLPVCJ-INIZCTEOSA-N 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 229960003444 immunosuppressant agent Drugs 0.000 abstract 3
- 239000003018 immunosuppressive agent Substances 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001861 immunosuppressant effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 238000012250 transgenic expression Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19711800A DE19711800A1 (de) | 1997-03-21 | 1997-03-21 | Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung |
| PCT/EP1998/001438 WO1998042338A1 (fr) | 1997-03-21 | 1998-03-12 | Prolongation de l'expression de proteines transgeniques par traitement immunomodulant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0969833T3 true DK0969833T3 (da) | 2003-09-15 |
Family
ID=7824118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98913712T DK0969833T3 (da) | 1997-03-21 | 1998-03-12 | Forlængelse af ekspressionen af transgene proteiner ved immunmodulerende behandling med 15-deoxyspergualin |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20030082151A1 (fr) |
| EP (1) | EP0969833B1 (fr) |
| JP (1) | JP2001518917A (fr) |
| AT (1) | ATE241356T1 (fr) |
| AU (1) | AU6831198A (fr) |
| DE (2) | DE19711800A1 (fr) |
| DK (1) | DK0969833T3 (fr) |
| ES (1) | ES2201473T3 (fr) |
| PT (1) | PT969833E (fr) |
| WO (1) | WO1998042338A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7691890B2 (en) | 1998-03-11 | 2010-04-06 | James W. Williams | Anti-viral uses of leflunomide products |
| EP1169036B1 (fr) * | 1998-03-11 | 2008-01-02 | James W. Williams | Utilisations antivirales de produits de leflunomide |
| CN1411373A (zh) * | 1999-12-16 | 2003-04-16 | 特瓦制药工业有限公司 | 制备来氟米特的新方法和新晶形的来氟米特 |
| WO2001048231A2 (fr) * | 1999-12-28 | 2001-07-05 | Novartis Ag | Procede de mise en oeuvre d'une expression persistante de transgenes |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9200275D0 (en) * | 1992-01-08 | 1992-02-26 | Roussel Lab Ltd | Chemical compounds |
| ATE174218T1 (de) * | 1993-01-08 | 1998-12-15 | Hoechst Ag | Verwendung von leflunomid zur hemmung von interleukin 1 beta |
| WO1996040170A2 (fr) * | 1995-06-07 | 1996-12-19 | Procept, Inc. | Composes contenant des metaux et leur utilisation pour inhiber la reponse immunitaire |
| US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
-
1997
- 1997-03-21 DE DE19711800A patent/DE19711800A1/de not_active Withdrawn
-
1998
- 1998-03-12 US US09/381,344 patent/US20030082151A1/en not_active Abandoned
- 1998-03-12 ES ES98913712T patent/ES2201473T3/es not_active Expired - Lifetime
- 1998-03-12 DE DE59808541T patent/DE59808541D1/de not_active Expired - Lifetime
- 1998-03-12 DK DK98913712T patent/DK0969833T3/da active
- 1998-03-12 EP EP98913712A patent/EP0969833B1/fr not_active Expired - Lifetime
- 1998-03-12 AT AT98913712T patent/ATE241356T1/de active
- 1998-03-12 WO PCT/EP1998/001438 patent/WO1998042338A1/fr not_active Ceased
- 1998-03-12 PT PT98913712T patent/PT969833E/pt unknown
- 1998-03-12 JP JP54481698A patent/JP2001518917A/ja active Pending
- 1998-03-12 AU AU68311/98A patent/AU6831198A/en not_active Abandoned
-
2007
- 2007-04-05 US US11/696,782 patent/US20070191299A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20030082151A1 (en) | 2003-05-01 |
| US20070191299A1 (en) | 2007-08-16 |
| EP0969833A1 (fr) | 2000-01-12 |
| JP2001518917A (ja) | 2001-10-16 |
| AU6831198A (en) | 1998-10-20 |
| DE59808541D1 (de) | 2003-07-03 |
| WO1998042338A1 (fr) | 1998-10-01 |
| ATE241356T1 (de) | 2003-06-15 |
| ES2201473T3 (es) | 2004-03-16 |
| DE19711800A1 (de) | 1998-09-24 |
| PT969833E (pt) | 2003-10-31 |
| EP0969833B1 (fr) | 2003-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991951L (no) | Tienopyrimidiner med fosfodiesterase V-inhiberende virkning | |
| MX9101869A (es) | Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas | |
| BR9006264A (pt) | Derivados de aminoacidos e processo para a sua producao,medicamentos,usos de um derivado de aminoacido e processo para tratamento ou prevencao de infeccoes viroticas | |
| EP0509019A4 (en) | Treatment of human retroviral infections with 2',3'-dideoxyinosine | |
| DK0414275T3 (da) | Fremgangsmåde til fremtilling af cycliske aminosyrederivater samt mellemprodukter | |
| HUT64314A (en) | Process for production isoxazole-4-carboxylic acid amides and hydroxi-alkylidene-cyanic-acetic acid amides and pharmaceutical preparations having these compounds | |
| FI955315A0 (fi) | HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon | |
| AP9701041A0 (en) | Pyridylpyrrole compounds. | |
| NO945034L (no) | Derivater i vitamin D-serien modifisert ved 20-stilling, en fremg. for frems. av slike derivater, mellomprodukter anvendt ved fremg., farmasöytiske preparater inneholdende derivatene og deres anvendelse ved frems. av legemidler | |
| FI980862A0 (fi) | Kiraalisia metyylifenyylioksatsolidinoneja | |
| ATE224714T1 (de) | Behandlung von tinnitus mit neuroprotektiven wirkstoffen | |
| NO20002702L (no) | Tienopyrimidiner | |
| DE69818678D1 (de) | (+)-norcisapride verwendbar bei 5-ht3 und 5-ht4 bedingten krankheiten | |
| ES2114117T3 (es) | Acidos fenilalcan(en)oicos con actividad antagonista del leucotrieno b4. | |
| EP0295538A3 (fr) | Inhibiteurs de la transformation de glycoprotéine ayant une activité antirétrovirale | |
| DK0969833T3 (da) | Forlængelse af ekspressionen af transgene proteiner ved immunmodulerende behandling med 15-deoxyspergualin | |
| CA2282279A1 (fr) | Atropisomeres de 3-heteroaryl-4(3h)-quinazolinones pour le traitement des troubles neurodegeneratifs et des troubles lies a un traumatisme du systeme nerveux central | |
| ATE46518T1 (de) | Sialosylcerebroside und verfahren zu ihrer herstellung. | |
| NO982863L (no) | Nye forbindelser med analgetisk effekt | |
| NO921906D0 (no) | Nye 2-amino-5-cyano-1,4-dihydropyridiner, deres fremstilling og anvendelse i legemidler | |
| ATE81118T1 (de) | Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten. | |
| NO307757B1 (no) | Uretanholdige aminosteroidforbindelser, farmasøytisk preparat samt anvendelse | |
| FI911533A7 (fi) | Bentsoksatsiini-johdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö sairauksien hoitamiseen tai ennalta ehkäisemiseksi | |
| NO953573L (no) | Benzopyraner som kaliumkanalåpnere | |
| NO20021310L (no) | Aminderivater |